Anales MédicosAntecedentes: La insuficiencia cardiaca (IC) es un síndrome clínico que suele ser consecuencia final de enfermedades cardiacas preexistentes, el uso de sacubitril-valsartán pretende reducir la mortalidad y mejorar la calidad de vida (CV).
Maricarmen Tapia-Venancio +8 more
doaj +1 more source
Re: Implication of low‐dose sacubitril/valsartan
, 2021 Amitabh C. Pandey, J. Thomas Heywood
openalex +1 more source
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan
, 2020 Scott D. Solomon +15 more
openalex +1 more source
Sacubitril/Valsartan and B-Type Natriuretic Peptide Value: Recalculating Route [PDF]
, 2019 M Abellas Sequeiros +4 more
openalex +1 more source
Sacubitril/Valsartan Shows Improvement of the Cardio-Ankle Vascular Index in a Hypertensive Patient
, 2023 Kazuhiro Shimizu +4 more
openalex +2 more sources
Reply to 'Sacubitril/valsartan in heart failure: a critical look at dementia risk and future study pathways'. [PDF]
Eur Heart J Cardiovasc PharmacotherJung K, Shin JY, Kim JH.
europepmc +1 more source
Sacubitril/valsartan in heart failure: a critical look at dementia risk and future study pathways. [PDF]
Eur Heart J Cardiovasc PharmacotherDong W, Li W.
europepmc +1 more source
The Cost-Effectiveness of Sacubitril/Valsartan for The Treatment of Chronic Heart Failure with Reduced Ejection Fraction in England and Scotland: Applying Real-World Evidence to Enhance Generalisability to A UK Population [PDF]
, 2016 David Trueman +8 more
openalex +1 more source